• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合基因组分析确定扩张型心肌病的分子亚组并基于机器学习方法识别新型生物标志物。

Integrated genomic analysis defines molecular subgroups in dilated cardiomyopathy and identifies novel biomarkers based on machine learning methods.

作者信息

Ye Ling-Fang, Weng Jia-Yi, Wu Li-Da

机构信息

Changzhi People's Hospital, Changzhi, Shanxi, China.

Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.

出版信息

Front Genet. 2023 Feb 7;14:1050696. doi: 10.3389/fgene.2023.1050696. eCollection 2023.

DOI:10.3389/fgene.2023.1050696
PMID:36824437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9941670/
Abstract

As the most common cardiomyopathy, dilated cardiomyopathy (DCM) often leads to progressive heart failure and sudden cardiac death. This study was designed to investigate the molecular subgroups of DCM. Three datasets of DCM were downloaded from GEO database (GSE17800, GSE79962 and GSE3585). After log2-transformation and background correction with "" package in R software, the three datasets were merged into a metadata cohort. The consensus clustering was conducted by the "" package to uncover the molecular subgroups of DCM. Moreover, clinical characteristics of different molecular subgroups were compared in detail. We also adopted Weighted gene co-expression network analysis (WGCNA) analysis based on subgroup-specific signatures of gene expression profiles to further explore the specific gene modules of each molecular subgroup and its biological function. Two machine learning methods of LASSO regression algorithm and SVM-RFE algorithm was used to screen out the genetic biomarkers, of which the discriminative ability of molecular subgroups was evaluated by receiver operating characteristic (ROC) curve. Based on the gene expression profiles, heart tissue samples from patients with DCM were clustered into three molecular subgroups. No statistical difference was found in age, body mass index (BMI) and left ventricular internal diameter at end-diastole (LVIDD) among three molecular subgroups. However, the results of left ventricular ejection fraction (LVEF) statistics showed that patients from subgroup 2 had a worse condition than the other group. We found that some of the gene modules (pink, black and grey) in WGCNA analysis were significantly related to cardiac function, and each molecular subgroup had its specific gene modules functions in modulating occurrence and progression of DCM. LASSO regression algorithm and SVM-RFE algorithm was used to further screen out genetic biomarkers of molecular subgroup 2, including , , , , , and . The results of ROC curves showed that all of the genetic biomarkers had favorable discriminative effectiveness. Patients from different molecular subgroups have their unique gene expression patterns and different clinical characteristics. More personalized treatment under the guidance of gene expression patterns should be realized.

摘要

作为最常见的心肌病,扩张型心肌病(DCM)常导致进行性心力衰竭和心源性猝死。本研究旨在探究DCM的分子亚组。从GEO数据库(GSE17800、GSE79962和GSE3585)下载了三个DCM数据集。在使用R软件中的“”包进行log2转换和背景校正后,将这三个数据集合并为一个元数据队列。通过“”包进行一致性聚类以揭示DCM的分子亚组。此外,还详细比较了不同分子亚组的临床特征。我们还基于基因表达谱的亚组特异性特征采用加权基因共表达网络分析(WGCNA)来进一步探索每个分子亚组的特定基因模块及其生物学功能。使用LASSO回归算法和SVM - RFE算法这两种机器学习方法筛选出遗传生物标志物,其中通过受试者工作特征(ROC)曲线评估分子亚组的判别能力。基于基因表达谱,DCM患者的心脏组织样本被聚类为三个分子亚组。三个分子亚组在年龄、体重指数(BMI)和舒张末期左心室内径(LVIDD)方面未发现统计学差异。然而,左心室射血分数(LVEF)统计结果显示,亚组2的患者病情比其他组更差。我们发现WGCNA分析中的一些基因模块(粉色、黑色和灰色)与心脏功能显著相关,并且每个分子亚组在调节DCM的发生和发展方面具有其特定的基因模块功能。使用LASSO回归算法和SVM - RFE算法进一步筛选出亚组2的遗传生物标志物,包括 、 、 、 、 、 和 。ROC曲线结果显示,所有遗传生物标志物均具有良好的判别效能。不同分子亚组的患者具有独特的基因表达模式和不同的临床特征。应在基因表达模式的指导下实现更个性化的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/bc945d78a9ac/fgene-14-1050696-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/f3407787cb3d/fgene-14-1050696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/078936acac2f/fgene-14-1050696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/4b6800f2a5a1/fgene-14-1050696-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/99de66ae76b9/fgene-14-1050696-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/e5f5732b561c/fgene-14-1050696-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/c4e732c35f97/fgene-14-1050696-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/b5ed2aedb682/fgene-14-1050696-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/ca7c91ae3fcc/fgene-14-1050696-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/364d7b06a7d1/fgene-14-1050696-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/bc945d78a9ac/fgene-14-1050696-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/f3407787cb3d/fgene-14-1050696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/078936acac2f/fgene-14-1050696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/4b6800f2a5a1/fgene-14-1050696-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/99de66ae76b9/fgene-14-1050696-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/e5f5732b561c/fgene-14-1050696-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/c4e732c35f97/fgene-14-1050696-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/b5ed2aedb682/fgene-14-1050696-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/ca7c91ae3fcc/fgene-14-1050696-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/364d7b06a7d1/fgene-14-1050696-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b2e/9941670/bc945d78a9ac/fgene-14-1050696-g010.jpg

相似文献

1
Integrated genomic analysis defines molecular subgroups in dilated cardiomyopathy and identifies novel biomarkers based on machine learning methods.综合基因组分析确定扩张型心肌病的分子亚组并基于机器学习方法识别新型生物标志物。
Front Genet. 2023 Feb 7;14:1050696. doi: 10.3389/fgene.2023.1050696. eCollection 2023.
2
Novel algorithm for diagnosis of Arrhythmogenic cardiomyopathy and dilated cardiomyopathy: Key gene expression profiling using machine learning.一种用于心律失常性心肌病和扩张型心肌病诊断的新算法:基于机器学习的关键基因表达谱分析。
J Gene Med. 2023 Mar;25(3):e3468. doi: 10.1002/jgm.3468. Epub 2022 Dec 19.
3
Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq.扩张型心肌病生物标志物和免疫微环境研究:来自 RNA-seq 的证据。
BMC Cardiovasc Disord. 2022 Jul 18;22(1):320. doi: 10.1186/s12872-022-02759-7.
4
Integrated analysis of WGCNA and machine learning identified diagnostic biomarkers in dilated cardiomyopathy with heart failure.加权基因共表达网络分析(WGCNA)与机器学习的综合分析确定了扩张型心肌病伴心力衰竭的诊断生物标志物。
Front Cell Dev Biol. 2022 Dec 5;10:1089915. doi: 10.3389/fcell.2022.1089915. eCollection 2022.
5
Identification of cuproptosis-related biomarkers in dilated cardiomyopathy and potential therapeutic prediction of herbal medicines.扩张型心肌病中铜死亡相关生物标志物的鉴定及草药的潜在治疗预测
Front Mol Biosci. 2023 Apr 24;10:1154920. doi: 10.3389/fmolb.2023.1154920. eCollection 2023.
6
Identification of cuproptosis-related genes and immune infiltration in dilated cardiomyopathy.扩张型心肌病中铜死亡相关基因的鉴定及免疫浸润
Int J Cardiol. 2024 Mar 15;399:131702. doi: 10.1016/j.ijcard.2023.131702. Epub 2023 Dec 31.
7
Analysis of potential genetic biomarkers using machine learning methods and immune infiltration regulatory mechanisms underlying atrial fibrillation.基于机器学习方法和房颤免疫浸润调控机制分析潜在的遗传生物标志物。
BMC Med Genomics. 2022 Mar 19;15(1):64. doi: 10.1186/s12920-022-01212-0.
8
Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy.扩张型心肌病潜在治疗靶点及免疫浸润特征的综合生物信息学分析
Ann Transl Med. 2022 Mar;10(6):348. doi: 10.21037/atm-22-732.
9
An Robust Rank Aggregation and Least Absolute Shrinkage and Selection Operator Analysis of Novel Gene Signatures in Dilated Cardiomyopathy.扩张型心肌病中新型基因特征的稳健秩聚合及最小绝对收缩和选择算子分析
Front Cardiovasc Med. 2021 Dec 14;8:747803. doi: 10.3389/fcvm.2021.747803. eCollection 2021.
10
Identification of Biomarkers Associated with Heart Failure Caused by Idiopathic Dilated Cardiomyopathy Using WGCNA and Machine Learning Algorithms.使用加权基因共表达网络分析(WGCNA)和机器学习算法鉴定与特发性扩张型心肌病所致心力衰竭相关的生物标志物
Int J Genomics. 2023 Apr 25;2023:2250772. doi: 10.1155/2023/2250772. eCollection 2023.

引用本文的文献

1
Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.基于集成机器学习的肥厚型心肌病诊断基因生物标志物预测。
J Int Med Res. 2023 Nov;51(11):3000605231213781. doi: 10.1177/03000605231213781.

本文引用的文献

1
Challenging molecular dogmas in human sepsis using mathematical reasoning.运用数学推理挑战人类脓毒症中的分子教条。
EBioMedicine. 2022 Jun;80:104031. doi: 10.1016/j.ebiom.2022.104031. Epub 2022 May 3.
2
Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer.用于预测宫颈癌临床结局和治疗反应的肿瘤微环境及DNA甲基化相关预后标志物的鉴定
Front Mol Biosci. 2022 Apr 19;9:872932. doi: 10.3389/fmolb.2022.872932. eCollection 2022.
3
Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
鉴定免疫浸润相关基因作为肝细胞癌的预后指标。
BMC Cancer. 2022 May 5;22(1):496. doi: 10.1186/s12885-022-09587-0.
4
Application of artificial intelligence in diagnosis of pancreatic malignancies by endoscopic ultrasound: a systemic review.人工智能在内镜超声诊断胰腺恶性肿瘤中的应用:一项系统评价
Therap Adv Gastroenterol. 2022 Apr 29;15:17562848221093873. doi: 10.1177/17562848221093873. eCollection 2022.
5
Assembly and function of branched ubiquitin chains.支化泛素链的组装和功能。
Trends Biochem Sci. 2022 Sep;47(9):759-771. doi: 10.1016/j.tibs.2022.04.003. Epub 2022 May 1.
6
Role of Branched-Chain Amino Acid Metabolism in Type 2 Diabetes, Obesity, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease.支链氨基酸代谢在 2 型糖尿病、肥胖症、心血管疾病和非酒精性脂肪肝疾病中的作用。
Int J Mol Sci. 2022 Apr 13;23(8):4325. doi: 10.3390/ijms23084325.
7
PDE4DIP in health and diseases.PDE4DIP 在健康和疾病中的作用。
Cell Signal. 2022 Jun;94:110322. doi: 10.1016/j.cellsig.2022.110322. Epub 2022 Mar 26.
8
Analysis of potential genetic biomarkers using machine learning methods and immune infiltration regulatory mechanisms underlying atrial fibrillation.基于机器学习方法和房颤免疫浸润调控机制分析潜在的遗传生物标志物。
BMC Med Genomics. 2022 Mar 19;15(1):64. doi: 10.1186/s12920-022-01212-0.
9
Design and rationale for a comparison study of Olmesartan and Valsartan On myocardial metabolism In patients with Dilated cardiomyopathy (OVOID) trial: study protocol for a randomized controlled trial.奥美沙坦和缬沙坦对扩张型心肌病患者心肌代谢影响比较研究的设计和原理(OVOID 试验):一项随机对照试验研究方案。
Trials. 2022 Jan 15;23(1):36. doi: 10.1186/s13063-021-05970-7.
10
Review of Insulin Resistance in Dilated Cardiomyopathy and Implications for the Pediatric Patient Short Title: Insulin Resistance DCM and Pediatrics.扩张型心肌病中的胰岛素抵抗综述及其对儿科患者的意义 短标题:胰岛素抵抗、扩张型心肌病与儿科
Front Pediatr. 2021 Oct 28;9:756593. doi: 10.3389/fped.2021.756593. eCollection 2021.